1 BTC
=
- USD
Danaher Corporation
As of June 27, 2026 at 06:20 UTC
Chart
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
DHR in Bitcoin terms
Danaher Corporation is tracked on Roxom Terminal for users who want to follow and trade global stocks in a Bitcoin-denominated market environment.
- Danaher Corporation is categorized under INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL.
- BTC-denominated charting frames stock performance against Bitcoin instead of fiat alone.
- The global terminal hub links individual stock pages into a crawlable BTC-native market map.
Market Statistics
Trading Metrics
How to Buy DHR
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy DHR
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesBio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies within three years.
The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance technologies. Repair and maintenance services represent the largest market segment, with North America dominating and Asia Pacific showing the fastest growth.
Danaher's stock has fallen 22% this year following its $9.9 billion acquisition of Masimo, which expands the company into clinical patient monitoring. Despite integration risks and a patent dispute with Apple, Danaher reported strong Q1 results with 3% revenue growth and raised 2026 EPS guidance. The company is seeing 30% year-over-year growth in equipment orders, benefiting from a resurgence in life sciences M&A activity. Trading at 20x forward earnings—below its historical average—the stock may represent a buying opportunity if management successfully integrates Masimo.
The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North America and Europe are leading markets, with Asia-Pacific emerging as the fastest-growing region.
The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.
